Mechanism of activation of a human oncogene
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The oncogene of the human EJ bladder carcinoma cell lines arose via alteration of a cellular proto-oncogene. Experiments are presented that localize the genetic lesion that led to activation of the oncogene. The lesion has no affect on levels of expression of the oncogene. Instead, it affects the structure of the oncogene-encoded protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [76]
Citations
Cites
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
A new method for sequencing DNA.
Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,922
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
McCann, J., Choi, E., Yamasaki, E., & Ames, B. N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5135 · Cited by 3,323
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Spragg, S. P. (1979) · Nature · doi:10.1038/278085a0 · Cited by 1,707
Transformation of mammalian cells with genes from procaryotes and eucaryotes
Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., & Axel, R. (1979) · Cell · doi:10.1016/0092-8674(79)90093-x · Cited by 1,408
DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.
Manley, J. L., Fire, A., Cano, A., Sharp, P. A., & Gefter, M. L. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3855 · Cited by 1,211
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citation
Research works printed but not linked: 1
- Ellis, R. W., DeFeo, D., Furth, M. E. & Scolnick, E. M. Cell (in the press).
Cited by
Items 401–500 of 1,000
Activation of N-ras gene in bone marrow cells from a patient with acute myeloblastic leukaemia
Gambke, C., Signer, E., & Moroni, C. (1984) · Nature · doi:10.1038/307476a0 · Cited by 60
Abbasi, A., & Alexandrov, L. B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103200 · Cited by 63
Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene
Koizumi, M., Kamiya, H., & Ohtsuka, E. (1992) · Gene · doi:10.1016/0378-1119(92)90727-7 · Cited by 59
Deguchi, H., Hamano, H., & Hayashi, Y. (1993) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1993.tb01152.x · Cited by 58
Characterization of functional domains of p21 ras by use of chimeric genes.
Schejter, E. D., & Shilo, B. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03643.x · Cited by 58
Oncogene expression in rat hepatomas and during hepatocarcinogenesis
Cote, G. J., Lastra, B. A., Cook, J. R., Huang, D.-P., & Chiu, J.-F. (1985) · Cancer Letters · doi:10.1016/0304-3835(85)90017-5 · Cited by 58
Schaefer, R., Iyer, J., Iten, E., & Nirkko, A. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1590 · Cited by 58
Cichutek, K., & Duesberg, P. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2340 · Cited by 58
Biological Consequences of Reactions with DNA: Role of Specific Lesions
Margison, G. P., & O'Connor, P. J. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74775-5_14 · Cited by 58
40 Years of RAS—A Historic Overview
Fernández‐Medarde, A., Rivas, J. D. L., & Santos, E. (2021) · Genes · doi:10.3390/genes12050681 · Cited by 61
Scheffer, J., Chen, C., Heidrich, P., Dickman, M. B., & Tudzynski, P. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.7.1228-1238.2005 · Cited by 57
Iwamoto, A., Omote, H., Hanada, H., Tomioka, N., Itai, A., Maeda, M., & Futai, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55304-7 · Cited by 57
Significance of chromosome change to hematopoietic neoplasms
CHAGANTI, R. S. K. (1983) · Blood · doi:10.1182/blood.v62.3.515.515 · Cited by 57
Pirollo, K. F., Garner, R. M., Yuan, S., Li, L., Blattner, W. A., & Chang, E. H. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914550831 · Cited by 57
Self-citationDose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones
Sistonen, L., Keski‐Oja, J., Ulmanen, I., Hölttä, E., Wikgren, B.-J., & Alitalo, K. K. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90024-3 · Cited by 57
Srivastava, A., Norris, J. S., Reis, R. J. S., & Goldstein, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88987-6 · Cited by 57
Chromosomal assignment of a family of human oncogenes.
Ryan, J., Barker, P. E., Shimizu, K., Wigler, M. H., & Ruddle, F. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4460 · Cited by 57
Insertional Oncogenesis by Non-Acute Retroviruses: Implications for Gene Therapy
Fan, H., & Johnson, C. (2011) · Viruses · doi:10.3390/v3040398 · Cited by 60
Enhancer activity correlates with the oncogenic potential of avian retroviruses.
Weber, F., & Schaffner, W. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03723.x · Cited by 56
Chromosome assignments of four mouse cellular homologs of sarcoma and leukemia virus oncogenes.
Sakaguchi, A. Y., Lalley, P. A., Zabel, B., Ellis, R. W., Scolnick, E. M., & Naylor, S. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.525 · Cited by 56
Self-citationNucleotide Sequence of the Rasheed Rat Sarcoma Virus Oncogene: New Mutations
Rasheed, S., Norman, G. L., & Heidecker, G. (1983) · Science · doi:10.1126/science.6344220 · Cited by 56
Proto‐Oncogenes in Development and Cancer
Torry, D. S., & Cooper, G. M. (1991) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1991.tb01080.x · Cited by 61
Overcoming KRAS-Mutant Lung Cancer
Luo, J., Ostrem, J. M. L., Pellini, B., Imbody, D., Stern, Y. E., Solanki, H. S., Haura, E. B., & Villaruz, L. C. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_360354 · Cited by 59
Gallo, M. L., Lozy, F., & Bell, D. W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_5 · Cited by 55
Triple-negative breast cancer: investigating potential molecular therapeutic target
Papa, A., Caruso, D., Tomao, F., Rossi, L., Zaccarelli, E., & Tomao, F. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.970176 · Cited by 58
A unified theory for the development of cancer
Spandidos, D. A. (1986) · Bioscience Reports · doi:10.1007/bf01116536 · Cited by 55
Activation of rat c-raf during transfection of hepatocellular carcinoma DNA.
Ishikawa, F., Takaku, F., Hayashi, K., Nagao, M., & Sügimura, T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3209 · Cited by 55
Tissue Localization of Drosophila melanogaster ras Transcripts during Development
Segal, D., & Shilo, B. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.6.2241-2248.1986 · Cited by 55
Benjamin, C. W., Tarpley, W. G., & Gorman, R. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.546 · Cited by 55
Willumsen, B. M., Vass, W. C., Velu, T. J., Papageorge, A. G., Schiller, J. T., & Lowy, D. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6026 · Cited by 54
Self-citationDevelopment and growth of early preneoplastic lesions induced in the liver by chemical carcinogens
Rabes, H. M. (1983) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00395384 · Cited by 54
KRAS mutant lung cancer: progress thus far on an elusive therapeutic target
Bhattacharya, S., Socinski, M. A., & Burns, T. F. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0075-0 · Cited by 62
Masui, H., Wells, A. H., Lazar, C. S., Rosenfeld, M. G., & Gill, G. N. (1991) · PubMed · Cited by 58
Spandidos, D. A., & Holmes, L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81014-1 · Cited by 53
GTP: A Central Regulator of Cellular Anabolism
Pall, M. L. (1985) · Current topics in cellular regulation · doi:10.1016/b978-0-12-152825-6.50005-9 · Cited by 53
Hurlin, P. J., Fry, D. G., Maher, V. M., & McCormick, J. J. (1987) · PubMed · Cited by 53
Harper, J. R., Roop, D. R., & Yuspa, S. H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3144-3149.1986 · Cited by 53
Human Cancer-Associated Antigens: Present Status and Implications for Immunodiagnosis
Sulitzeanu, D. (1985) · Advances in cancer research · doi:10.1016/s0065-230x(08)60024-x · Cited by 53
The Emerging Genetics of Human Cancer
Epstein, F. H., & Krontiris, T. G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090704 · Cited by 53
Holzmann, B., Johnson, J. P., Kaudewitz, P., & Riethmüller, G. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.2.366 · Cited by 53
Genetic and Biochemical Alterations in Non-Small Cell Lung Cancer
Johnson, J. L., Pillai, S., & Chellappan, S. (2012) · Biochemistry Research International · doi:10.1155/2012/940405 · Cited by 59
Sell, S. (1990) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30580-8 · Cited by 56
Mutational activation of the c-K-ras gene in human pancreatic carcinoma
Shibata, D. K., Capellá, G., & Perucho, M. (1990) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(90)90044-h · Cited by 52
Panayotatos, N., Radziejewska, E., Acheson, A. L., Pearsall, D., Thadani, A., & Wong, V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46726-3 · Cited by 52
Lacal, J. C., & Aaronson, S. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4214 · Cited by 52
McMahon, S. B., & Monroe, J. G. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.417 · Cited by 52
Westaway, D. A., Papkoff, J. S., Moscovici, C., & VARMUS, H. E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04213.x · Cited by 52
Zheng, L., Liu, C., & Yu, K. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01522-5 · Cited by 56
The genetic origins of human cancer
Weinberg, R. A. (1988) · Cancer · Cited by 51
Self-citationOligomeric structure of p21 ras proteins as determined by radiation inactivation.
Santos, E., Nebreda, Á. R., Bryan, T., & Kempner, E. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81595-8 · Cited by 51
Kuzmich, S., Marky, L. A., & Jones, R. A. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.10.3393 · Cited by 51
Hsu, S.-Y., Noumi, T., Takeyama, M., Maeda, M., Ishibashi, S., & Futai, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81050-5 · Cited by 51
Linz, J. E., Lira, L. M., & Sypherd, P. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66823-1 · Cited by 51
Photoaffinity labeling with GTP of viral p21 ras protein expressed in Escherichia coli
Stein, R. B., Robinson, P. S., & Scolnick, E. M. (1984) · Journal of Virology · doi:10.1128/jvi.50.2.343-351.1984 · Cited by 51
Self-citationFrequency of H‐ ras mutations in human bladder cancer detected by direct sequencing
Burchill, S. A., Neal, D. E., & Lunec, J. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb07636.x · Cited by 50
Hua, V. Y., Wang, W. K., & DUESBERG, P. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9614 · Cited by 50
Mohn, G. R., Kerklaan, P. R. M., van Zeeland, A. A., Ellenberger, J., Baan, R. A., Lohman, P. H. M., & Pons, F. W. (1984) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(84)90067-8 · Cited by 50
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)
Pollard, C., Smith, S. C., & Theodorescu, D. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001407 · Cited by 52
Takeyama, M., Ihara, K., Moriyama, Y., Noumi, T., Ida, K., Tomioka, N., Itai, A., Maeda, M., & Futai, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45357-9 · Cited by 49
Proto‐oncogene amplification and homogeneously staining regions in human breast carcinomas
Saint‐Ruf, C., Gerbault‐Seureau, M., Viégas-Pèquignot, E., Sigal‐Zafrani, B., Cassingena, R., & Dutrillaux, B. (1990) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870020105 · Cited by 49
Expression of oncogenes in human tumours with special reference to the head and neck region
Field, J. K., & Spandidos, D. A. (1987) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1987.tb01474.x · Cited by 49
van Hille, B., Duponchel, N., Salomé, N., Spruyt, N., Cotmore, S. F., Tattersall, P. J., Cornelis, J. J., & Rommelaere, J. (1989) · Virology · doi:10.1016/0042-6822(89)90514-x · Cited by 49
Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets
Yu, L., Issaq, H. J., & Veenstra, T. D. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700102 · Cited by 48
Mutational analysis of gene families in human cancer
Bardelli, A., & Velculescu, V. E. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.009 · Cited by 48
Activation of the c-K-ras oncogene in a human pancreas carcinoma
Hirai, H., Okabe, T., ANRAKU, Y., Fujisawa, M., Urabe, A., & Takaku, F. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(85)80140-6 · Cited by 48
Lacal, J. C., & Aaronson, S. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.4.1002 · Cited by 47
Ogata, N., Kamimura, T., & Asakura, H. (1991) · Hepatology · doi:10.1002/hep.1840130106 · Cited by 47
Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.
Colby, W. W., Hayflick, J. S., Clark, S. G., & Levinson, A. D. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.2.730 · Cited by 42
Gambke, C., Hall, A., & Moroni, C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.879 · Cited by 51
A mutation at the major phosphotyrosine in pp60 alters oncogenic potential
Snyder, M. A., & Bishop, J. M. (1984) · Virology · doi:10.1016/0042-6822(84)90174-0 · Cited by 47
Pagé, M., Hall, A., Rhodes, S., Skinner, R. H., Murphy, V. F., Sydenham, M. A., & Lowe, P. N. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47280-3 · Cited by 47
Okudela, K., Woo, T., & Kitamura, H. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02580.x · Cited by 45
The cloning and characterization of a RAS gene fromSchizosaccharomyces pombe
Nadin‐Davis, S. A., Robert Che-An, Y. A. N. G., Narang, S. A., & Nasim, A. (1986) · Journal of Molecular Evolution · doi:10.1007/bf02100997 · Cited by 46
Hassan, S., Kinoshita, Y., Kawanami, C., Kishi, K., Matsushima, Y., Ohashi, A., Funasaka, Y., Okada, A., Maekawa, T., He-Yao, W., et al. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018851415704 · Cited by 45
Grimm, M., J�rgens, B., Schulz, W. A., Decken, K., Makri, D., & Schmitz-Dr�ger, B. J. (1995) · Urological Research · doi:10.1007/bf00300017 · Cited by 45
Hoffman, A. G., Burghardt, R. C., Tilley, R., & Auersperg, N. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540518 · Cited by 45
Paulie, S., Koho, H., Ben-Aissa, H., Hansson, Y., Lundblad, M., & Perlmann, P. (1984) · Cancer Immunology Immunotherapy · doi:10.1007/bf00205482 · Cited by 45
Cell-signaling targets for antitumour drug development
Brunton, V. G., & Workman, P. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685870 · Cited by 48
Rose, D. W., McCabe, G., Feramisco, J. R., & Adler, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.6.1405 · Cited by 45
Samid, D., Flessate, D. M., & Friedman, R. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.6.2196 · Cited by 45
Transforming Genes and Target Cells of Murine Spleen Focus-Forming Viruses
Ostertag, W., Stocking, C., Johnson, G. R., Kluge, N., Kollek, R., Franz, T., & Hess, N. K. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60693-4 · Cited by 47
More to the RAS Story: KRAS G12C Inhibition, Resistance Mechanisms, and Moving Beyond KRAS G12C
Lietman, C. D., Johnson, M. L., McCormick, F., & Lindsay, C. R. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_351333 · Cited by 44
Behforouz, M., Cai, W., Mohammadi, F., Stocksdale, M. G., Gu, Z., Ahmadian, M., Baty, D. E., Etling, M. R., Al-Anzi, C. H., Swiftney, T. M., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.039 · Cited by 44
Estrogen Inducibility of c-Ha-ras Transcription in Breast Cancer Cells
Pethe, V., & Shekhar, P. V. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30969 · Cited by 43
Invited review Oncogenes, growth, and the cell cycle: an overview
Studzinski, G. P. (1989) · Cell Proliferation · doi:10.1111/j.1365-2184.1989.tb00226.x · Cited by 55
Clarke, E. P., Jain, N. K., Brickenden, A. M., Lorimer, I. A. J., & Sanwal, B. D. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.1.193 · Cited by 46
Marcum, J. A. (2005) · International Studies in the Philosophy of Science · doi:10.1080/02698590500051076 · Cited by 49
Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene
Reddy, E. P., Lipman, D. J., Andersen, P. R., Tronick, S. R., & Aaronson, S. A. (1985) · Journal of Virology · doi:10.1128/jvi.53.3.984-987.1985 · Cited by 43
p21-ras effector domain mutants constructed by "cassette" mutagenesis.
Stone, J. C., Vass, W. C., Willumsen, B. M., & Lowy, D. R. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3565 · Cited by 43
Self-citationTargeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
Odeniyide, P., Yohe, M. E., Pollard, K., Vaseva, A. V., Calizo, A., Zhang, L., Rodríguez, F. J., Gross, J. M., Allen, A. N., Wan, X., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02305-x · Cited by 47
Activation of a human c-K-rasoncogeoe
Yamamoto, F., & Perucho, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.23.8873 · Cited by 42
Willumsen, B. M., Papageorge, A. G., Hubbert, N. L., Bekesi, E., Kung, H. F., & Lowy, D. R. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04019.x · Cited by 42
Self-citationCelis, J. E., Bravo, R., Larsen, P. M., Fey, S. J., Bellatin, J., & Celis, A. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-164720-9.50014-3 · Cited by 42
Oncogenes and Tumor Suppressor Genes
Klein, G. (1988) · Acta Oncologica · doi:10.3109/02841868809093569 · Cited by 46
Guerrero, I., Villasanté, A., D’Eustachio, P., & Pellicer, À. (1984) · Science · doi:10.1126/science.6089339 · Cited by 41
Papageorge, A. G., Defeo-Jones, D., Robinson, P., Temeles, G. L., & Scolnick, E. M. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.1.23-29.1984 · Cited by 41
Self-citationGarcia, I., Sordat, B., Rauccio-Farinon, E., Dunand, M., Kraehenbühl, J. P., & Diggelmann, H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.6.1974 · Cited by 41
Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
Huang, C.-Y., Zhao, J.-J., Lv, L. L., Chen, Y.-B., Li, Y., Jiang, S.-S., Wang, W., Pan, K., Zheng, Y., Zhao, B.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069155 · Cited by 40
Whole genome sequencing for lung cancer.
Daniels, M. G., Goh, F., Wright, C. M., Sriram, K. B., Relan, V., Clarke, B. E., Duhig, E., Bowman, R., Yang, I. A., & Fong, K. M. (2012) · PubMed · doi:10.3978/j.issn.2072-1439.2012.02.01 · Cited by 49
A structural perspective on targeting the RTK /Ras/ MAP kinase pathway in cancer
Heppner, D. E., & Eck, M. J. (2021) · Protein Science · doi:10.1002/pro.4125 · Cited by 43
Metadata
- Authors
- Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Nature
- Published
- 1982-11
- Volume
- 300
- Issue
- 5888
- Pages
- 143-149
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2013973825
- Cited by
- 1,393
- References
- 43
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 14 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 23 · 2015: 17 · 2014: 10 · 2013: 20 · 2012: 18
- FWCI
- 97.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Keywords
- oncogene activation, proto-oncogenes, bladder cancer, EJ cell line
- MeSH terms
- Proto-Oncogene Mas, Base Sequence, Urinary Bladder Neoplasms, Cell Line, Cell Transformation, Neoplastic, Cloning, Molecular, DNA Restriction Enzymes, Gene Expression Regulation, Humans, Molecular Weight, Mutation, Neoplasm Proteins, Oncogenes, RNA, Neoplasm, Transfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.